Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Compromise drug export bill unanimously clears Senate Labor Committee on Aug. 2.

This article was originally published in The Tan Sheet

Executive Summary

GREGG/KENNEDY COMPROMISE ON SENATE FDA EXPORT REFORM BILL approved unanimously by the 16 member Labor & Human Resources Commit-tee during an Aug. 2 markup. The compromise bill, sponsored by Sens. Judd Gregg (R-N.H.) and Edward Kennedy (D-Mass.) and entitled the "FDA Export Reform & Enhancement Act of 1995" (S 593), lists specific countries to which unapproved drugs and devices may be exported without FDA export approval.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084137

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel